Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Background</h3><p><i>Candida </i> species are considered as the cause of one of the most important opportunistic fungal diseases. Accurate identification of <i>Candida </i> species is important because of antifungal susceptibility patterns are different among these species, so proper identification helps in the selection of antifungal drugs for the prevention and treatment. Phenotypic methods for identification of <i>Candida </i> species, which are widely used in clinical microbiology laboratories, have some limitations. Real‐time PCR followed by the high‐resolution melting analysis (HRMA) is a novel approach for the rapid recognition of pathogenic fungi. Molecular phylogeny is essential for obtaining a better understanding of the evolution of the genus <i>Candida </i> and the identification of the relative degree of the <i>Candida </i> species. The purpose of this study was molecular identification of <i>Candida </i> isolates by Real‐time PCR‐high‐resolution melting analysis and investigation of the genetic diversity of <i>Candida </i> species. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Methods</h3><p>Two hundred and thirty‐two <i>Candida </i> isolates including 111 <i>Candida </i> isolates obtained from 96 HIV/AIDS patients and 121 <i>Candida </i> isolates obtained from 98 non‐HIV persons were identified by real‐time PCR and high‐resolution melting curve analysis. To evaluate genetic diversity and relationships among <i>Candida </i> species, PCR products of nine clinical <i>Candida </i> isolates, as a representative of each kind of species, were randomly selected for DNA sequence analysis. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>In HIV/AIDS patients, six species of <i>Candida </i> spp. were identified as follows: <i>C albicans </i> (n = 64; 57.7%), <i>C glabrata </i> (n = 31; 27.92%), <i>C parapsilosis </i> (n = 9; 8.1%), <i>C tropicalis </i> (n = 4; 3.6%), <i>C krusei </i> (n = 2; 1.8%), and <i>C kefyr </i> (n = 1; 0.90%). In non‐HIV persons, we identified eight species of <i>Candida </i> including <i>C albicans </i> (n = 46; 38.33%) followed by <i>C glabrata </i> and <i>C krusei </i> (each one, n = 18; 15%), <i>C tropicalis </i> (n = 13; 10.83%), <i>C lusitaniae </i> (n = 12; 5.17%), <i>C parapsilosis </i> (n = 10; 4.31%), and <i>C kefyr </i> and <i>C guillermondii </i> (each one, n = 2; 1.66%). Also, the phylogenetic analysis showed the presence of two main clades and six separate subclades. Accordingly, about 88.9% of the isolates were located in clade I and 11.10% of the studied isolates were in clade II. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusions</h3><p>Real‐time PCR followed by high‐resolution melting analysis (HRMA) is known as a reliable, fast, and simple approach for detection and accurate identification of <i>Candida </i> species, especially in clinical samples. </p></section>

Characteristics of Candida albicans Derived From HIV‐Positive Individuals With Oral Candidiasis: Genotyping, Phenotypic Variation, Antifungal Susceptibility, and Biofilm Formation

Oral Prevalence of Candida Species in Patients Undergoing Systemic Glucocorticoid Therapy and the Antifungal Sensitivity of the Isolates

Genotyping and Antifungal Susceptibility of Candida Albicans Isolates from AIDS Patients

A clinical analysis on 54 HIV/AIDS patients complicated with oral candidiasis

[In Vitro Study of Oral Candida Albicans in Virulence from HIV-positive Individuals].

Antifungal Susceptibility and Candida sp. Biofilm Production in Clinical Isolates of HIV-Positive Brazilian Patients under HAART Therapy

Changing Paradigm of Yeast Isolates in HIV-Seropositive Patients with Oropharyngeal Candidiasis (OPC)

Characterization of Oral Candidiasis and the Candida Species Profile in Patients with Oral Mucosal Diseases.

Antifungal susceptibility and virulence determinants profile of candida species isolated from patients with candidemia

Species distribution and antifungal susceptibility of Candida sp. isolates from AIDS patients with oropharyngeal candidiasis

Multilocus sequence typing of Candida albicans isolates from the oral cavities of patients undergoing haemodialysis

Evaluation of biofilm formation and antimicrobial susceptibility (drug resistance) of Candida albicans isolates

Candida species and oral mycobiota of patients clinically diagnosed with oral thrush

Antifungal Susceptibility and Genotypes of Candida Albicans Strains from Patients with Vulvovaginal Candidiasis

Molecular Genotyping of Candidaalbicans Isolated from Different Sites May Trace the Etiological Infection Routes: Observation in China

Molecular identification of Candida isolates by Real‐time PCR‐high‐resolution melting analysis and investigation of the genetic diversity of Candida species

Molecular Epidemiology, Antifungal Susceptibility, and Virulence Evaluation of Candida Isolates Causing Invasive Infection in a Tertiary Care Teaching Hospital

Relative Abundances of Candida albicans and Candida glabrata in In Vitro Coculture Biofilms Impact Biofilm Structure and Formation

Candida dubliniensis in Japanese Oral Microbiota: A Cross-Sectional Study of Six Geographic Regions in Japan

Different Host Immunological Response to C. Albicans by Human Oral and Vaginal Epithelial Cells

Antifungal Drug Susceptibility Profile of Candida kefyr Isolated from Clinical Samples and Dairy Products